MarginsXMarginsX
Home › Markets › Health Care › TTRX

Turn Therapeutics Inc. (TTRX)

TTRX trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$8.55
-8.51% on the day
Market cap
$261.4M
Micro cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerTTRX on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0002023016
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials

Not reported in SEC XBRL data.

Warning signs

Cash runway
21.4 months
$9.4M cash at September 30, 2026
Share count, 1 year
+3.8%
2025-11-12 to 2026-11-06
Going-concern doubt
No
10-Q filed November 9, 2026
Insider net buying, 12 months
$308K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.
"Our capital resources may not be sufficient to fund operations through at least the next 12 months from the date that these condensed consolidated financial statements as of September 30, 2026 are issued based on our expected cash needs, which raises substantial doubt about our ability to continue as a going concern."
10-Q 2026-11-09
Cash and burn$9.4M cash; operating cash flow -$1.3M a quarter.Report 2026-09-30
Shares outstanding30,572,704 (2026-11-06); 29,445,183 a year earlier.Cover page 2026-11-06
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months2 S-3/F-3 shelf filings; 0 424B5 takedownsLatest 2026-11-09
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorWithumSmith+Brown, PC, Whippany, New Jersey, United StatesPCAOB Form AP 2026-04-02
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $308K, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
Not filed-$6.2M-$1.5M$9.4M$7.3MNeeds four quarters10-Q 2026-11-09
Q2 2026
2026-06-30
Not filed-$5.8M-$923K$9.9M$7.3MNeeds four quarters10-Q 2026-11-09
Q1 2026
2026-03-31
Not filed-$971K-$1.6M$11.0M$7.3MNeeds four quarters10-Q 2026-11-09
Q4 2025
2025-12-31
Not filed$279K-$1.2M$4.0MNo debt tagsNeeds four quarters10-K 2026-03-31
Q3 2025
2025-09-30
Not filed-$1.9M-$589K$514KNo debt tagsNeeds four quarters10-Q 2026-11-09
Q2 2025
2025-06-30
Not filed-$1.2M-$500K$3.2MNo debt tagsNeeds four quarters10-Q 2026-11-09
Q1 2025
2025-03-31
Not filed-$329K-$298K$1.6MNo debt tagsNeeds four quarters10-Q 2026-11-09
Q4 2024
2024-12-31
Not filed-$323K-$431K$498KNo debt tagsNeeds four quarters10-K 2026-03-31

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
PROSPECTUS
424B52026-11-16
Latest annual report
ANNUAL REPORT
10-K2026-03-31
Latest quarterly / interim
QUARTERLY REPORT
10-Q2026-11-09
Latest current report
CURRENT REPORT
8-K2026-11-10
Latest proxy
PROXY STATEMENT
DEF 14A2026-10-19

Source: SEC EDGAR submissions feed, 129 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-1.4%
1 month-11.8%
3 months-5.2%
Year to date+137.2%
1 year+128.5%
From 52-week high-39.1%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
INOInovio Pharmaceuticals Inc.$1.40-2.10%$262.2M
PRLDPrelude Therapeutics Incorporated$3.41-1.16%$272.1M
QTTBQ32 Bio Inc.$8.29-4.82%$248.1M
LFCRLifecore Biomedical Inc.$6.42-0.08%$243.2M
CAMPCAMP4 Therapeutics Corporation$3.86+1.58%$242.2M
RCKTRocket Pharmaceuticals Inc.$2.16-6.09%$241.2M
FULCFulcrum Therapeutics Inc.$3.71-1.59%$283.4M
BIOABioAge Labs Inc.$5.22-5.95%$239.9M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier